Characterizing the KRAS G12C mutation in metastatic colorectal cancer: a population-based cohort and assessment of expression differences in The Cancer Genome Atlas.

Saved in:
Bibliographic Details
Title: Characterizing the KRAS G12C mutation in metastatic colorectal cancer: a population-based cohort and assessment of expression differences in The Cancer Genome Atlas.
Authors: Li M; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Keshavarz-Rahaghi F; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Ladua G; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Swanson L; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Speers C; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Renouf DJ; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Lim HJ; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Davies JM; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Gill S; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Stuart HC; Vancouver General Hospital, Vancouver, BC, Canada., Yip S; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Loree JM; BC Cancer, The University of British Columbia, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Jun 06; Vol. 14, pp. 17588359221097940. Date of Electronic Publication: 2022 Jun 06 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first